Peripheral nerve functions (MCV, SCV, M wave latency, T wave latency, continuotis evoked potential and post-tetanic action potential) were assessed in 34 patients on long-term diphenylhydantoin (DPH) therapy and were compared with those of a control group consisting of 22 subjects including 2 epileptic patients without DPH treat ment.
The results were as follows;
1) The MCV's were 47.6±9.3 m/sec in DPH group and 57.1±7.0 m/sec in the control group respectively. There was significant difference between two groups (t-test, P<0.05). The incidence of MCV below 2 standard deviations from the control mean was 32% in the DPH group, and none in the control group.
2) The SCV's were 45.2±10.9 m/sec in the DPH group and 56.7±7.0 m/sec in the control groups. There was significant difference between two groups (P<0.05). The incidence of individuals with SCV below 2 standard deviations from the control mean was 42% in the DPH group, whereas 5% in the control group.
3) For T wave latency, the correlation coefficient between T wave latency and the age was 0.6733 in the DPH group and 0.7460 in the control group. There was, however, no significant difference between the two groups.
4) M wave latency was delayed in the DPH group. There was a notistical significance bet ween the two groups (P<0.01).
5) The continuous evoked action potential and the post-tetanic action potential showed a waning phenomenon was in two patients of the DPH group and none in the control group.
6) Serum DPH determined concurrently ranged 13.8 to 0.3 r/m
l. The factors affecting on MCV, SCV, T wave latency and M wave latency (serum DPH levels, duration of therapy, total dosage (g/kg) and gum hypertrophy) were evaluated. There were correlations between duration of theray and T wave latency (r=0.4923, p<0.01), and between total dosage and MCV (r=-0.3584, P<0.05). The patients with gum hypertrophy showed significantly lower without gum hypertrophy. There was no significant correlation between the serum level of DPH and MCV, SCV or T wave latency. There was no significant correlation between M wave latency and serum level, duration of therapy or total dosage.
View full abstract